Who are Neurava's investors?

Neurava's investors include Elevate Ventures, First Leaf Capital, Sugati Ventures.

How much funding has Neurava raised?

Neurava has disclosed $4.2M raised across 3 of its 5 known rounds.

Where is Neurava headquartered?

Neurava is headquartered in Baltimore, US.

Neurava

Baltimore, US · Founded 2022 · Delaware corporation · 8 employees on LinkedIn · 3 known investors

Find your way into Neurava

254 people in our graph share verified history with the Neurava team — schools, employers, funds. One of them is your warm intro.

Jane Commerfordunlockedknows Trevor Meyer, PhD · together at Purdue University (overlapped)

×5knows the team · via Apple

×3knows the team · via Purdue University

×3knows the team · via Depuysynthes

Neurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy). The company combines neuromodulation expertise with machine learning to create a novel medical device platform for epilepsy management.

AI & Machine Learning Healthtech Medical Devices

Founders & leadership

Neurava was founded in 2022 by Vivek Ganesh, PhD, Jay Shah, PhD, Trevor Meyer, PhD, Vivek Ganesh, and Jay Shah.

Vivek Ganesh, PhDCo-founder

Jay Shah, PhDCo-founder

Trevor Meyer, PhD inCo-founderTrevor Meyer holds a PhD and has worked at Apple, Calvary Engineering, and DePuy Synthes in orthopedic device development, as well as served as a Head Teaching Assistant. He is co-founder of Neurava, which develops AI-powered wearable devices to monitor seizures and cardiorespiratory dysfunction in epilepsy patients.

Vivek Ganesh inCo-Chief Executive Officer & Co-FounderVivek Ganesh is Co-CEO and Co-Founder of Neurava, an AI-powered medical device company developing wearable technologies for seizure monitoring and epilepsy management. He has held executive and technical leadership roles in medical device startups, overseeing product development, regulatory strategy, and fundraising efforts.

Jay ShahinChief Executive Officer, Co-Founder

Board

Mona ChadhainBoard Director

Daniel MooreinBoard director

John KayBoard director

Investors · 3

Elevate Ventures✓ verifiedIndianapolis · $20K – $2M

First Leaf CapitalChampaign-Urbanavia Mark Aardsma · inferred

Sugati VenturesSan Ramon

Funding

SEC filings, press & company announcements

$4.2M disclosed across 3 of 5 rounds · 2021–2025

Undisclosed amountSeedApr 2024
Source ↗

▶$1.6MraisedOct 2025 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Mona ChadhaDirector
Vivek GaneshExecutive Officer, Director, Promoter
Daniel MooreDirector
Jay ShahExecutive Officer, Director, Promoter
John KayDirector

Offering amount: $7M
Amount sold: $1.6M
First sale: Oct 2025
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.9MraisedAug 2023 · 16 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Jay ShahExecutive Officer, Director, Promoter
Mona ChadhaDirector
Kristin EilenbergDirector
Vivek GaneshDirector

Offering amount: $2.5M
Amount sold: $1.9M
First sale: Dec 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$656.3KraisedSep 2021 · 9 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Jay ShahExecutive Officer, Director, Promoter
Vivek GaneshDirector

Offering amount: $750K
Amount sold: $656.3K
First sale: Aug 2021
Incorporated: Limited Liability Company, Indiana, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Renerva6 shared keywordsRenerva develops implantable medical devices to treat peripheral nerve injuries. The company was founded from academic research at the University of Pittsburgh and Cornell University.

Nura Bio5 shared keywordsNura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.

Companies competing with Neurava for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Neurava Raises $2.26M in Seed Fundingfinsmes.com · Apr 2024

Neurava raises over $2M to advance life-saving epilepsy monitoring deviceprnewswire.com · Apr 2024

Frequently asked questions

What does Neurava do?: Neurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy). The company combines neuromodulation expertise with machine learning to create a novel medical device platform for epilepsy management.
Who founded Neurava?: Neurava was founded by Vivek Ganesh, PhD, Jay Shah, PhD, Trevor Meyer, PhD, Vivek Ganesh, Jay Shah in 2022.
Who are Neurava's investors?: Neurava's investors include Elevate Ventures, First Leaf Capital, Sugati Ventures.
How much funding has Neurava raised?: Neurava has disclosed $4.2M raised across 3 of its 5 known rounds.
Where is Neurava headquartered?: Neurava is headquartered in Baltimore, US.